scispace - formally typeset
B

Bhawani Aryasomayajula

Researcher at Northeastern University

Publications -  8
Citations -  400

Bhawani Aryasomayajula is an academic researcher from Northeastern University. The author has contributed to research in topics: Efficacy & Head and neck cancer. The author has an hindex of 4, co-authored 8 publications receiving 312 citations.

Papers
More filters
Journal ArticleDOI

Barriers to drug delivery in solid tumors

TL;DR: This review hopes to provide the reader with a clear understanding and knowledge of biological barriers and the methods to exploit these characteristics to design multifunctional nanocarriers, effect useful dosing regimens and subsequently improve therapeutic outcomes in the clinic.
Journal ArticleDOI

Solid lipid nanoparticles co-loaded with doxorubicin and α-tocopherol succinate are effective against drug-resistant cancer cells in monolayer and 3-D spheroid cancer cell models.

TL;DR: Solid lipid nanoparticles co-loaded with doxorubicin and TS showed a prominent cytotoxicity and a greater penetration of doxorbicin in cancer cell spheroids and in the monolayer model, suggesting a bypassing of P-glycoprotein bomb efflux.
Journal ArticleDOI

Cancer cell spheroids for screening of chemotherapeutics and drug-delivery systems

TL;DR: In this review, production of cancer cell spheroids, utilization of these sp Heroids in understanding various therapeutic mechanisms and the potential for their use in high-throughput screening of drugs and drug-delivery systems are discussed in detail.
Journal ArticleDOI

Erratum to: Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model.

TL;DR: To develop transferrin (Tf)-targeted delivery systems for the pro-apoptotic drug, NCL-240, and to evaluate the efficacy of this delivery system in ovarian cancer NCI/ADR-RES cells, grown in vitro in a 3D spheroid model.
Journal Article

Safety and efficacy of quadrapeutics versus chemoradiation in head and neck carcinoma xenograft model

TL;DR: In this paper, the authors compared cell-level combination approach, quadrapeutics, to chemoradiation therapy to establish pre-clinical data for its biodistribution, safety and efficacy in head and neck squamous cell carcinoma (HNSCC), as a clinically challenging aggressive and resistant cancer.